1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Ocular Drug Delivery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Ocular Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Ocular Drug Delivery Market Regional Analysis
6.2 Europe Ocular Drug Delivery Market Revenue 2019-2028 (US$ Million)
6.3 Europe Ocular Drug Delivery Market Forecast Analysis
7. Europe Ocular Drug Delivery Market Analysis – by Technology
7.1 Implantable Ocular Drug Delivery Systems
- 7.1.1 Overview
- 7.1.2 Implantable Ocular Drug Delivery Systems: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Particulate Drug Delivery Systems
- 7.2.1 Overview
- 7.2.2 Particulate Drug Delivery Systems: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Nano-Particle Drug Delivery System
- 7.3.1 Overview
- 7.3.2 Nano-Particle Drug Delivery System: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Ocular Drug Delivery Market Analysis – by Formulation Type
8.1 Liposomes and Nanoparticles
- 8.1.1 Overview
- 8.1.2 Liposomes and Nanoparticles: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Solution
- 8.2.1 Overview
- 8.2.2 Solution: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Emulsion
- 8.3.1 Overview
- 8.3.2 Emulsion: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Suspension
- 8.4.1 Overview
- 8.4.2 Suspension: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Ointment
- 8.5.1 Overview
- 8.5.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Ocular Drug Delivery Market Analysis – by Disease Type
9.1 Glaucoma
- 9.1.1 Overview
- 9.1.2 Glaucoma: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diabetic Retinopathy
- 9.2.1 Overview
- 9.2.2 Diabetic Retinopathy: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Dry Eye Syndrome
- 9.3.1 Overview
- 9.3.2 Dry Eye Syndrome: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Macular Degeneration
- 9.4.1 Overview
- 9.4.2 Macular Degeneration: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Cataract
- 9.5.1 Overview
- 9.5.2 Cataract: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.6 Diabetic Macular Edema
- 9.6.1 Overview
- 9.6.2 Diabetic Macular Edema: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Ocular Drug Delivery Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Ophthalmic Clinics
- 10.2.1 Overview
- 10.2.2 Ophthalmic Clinics: Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Ambulatory Surgical Centers
- 10.3.1 Overview
- 10.3.2 Ambulatory Surgical Centers : Europe Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Europe Ocular Drug Delivery Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Ocular Drug Delivery Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 11.2.1.1 Europe Ocular Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 UK: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.1.2 UK: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.1.3 UK: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.1.4 UK: Europe Ocular Drug Delivery Market Breakdown, by End User
- 11.2.1.2 Germany:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Germany: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.2.2 Germany: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.2.3 Germany: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.2.4 Germany: Europe Ocular Drug Delivery Market Breakdown, by End User
- 11.2.1.3 France:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 France: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.3.2 France: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.3.3 France: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.3.4 France: Europe Ocular Drug Delivery Market Breakdown, by End User
- 11.2.1.4 Russia:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Russia: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.4.2 Russia: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.4.3 Russia: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.4.4 Russia: Europe Ocular Drug Delivery Market Breakdown, by End User
- 11.2.1.5 Italy:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Italy: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.5.2 Italy: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.5.3 Italy: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.5.4 Italy: Europe Ocular Drug Delivery Market Breakdown, by End User
- 11.2.1.6 Rest of Europe:
Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Technology
- 11.2.1.6.2 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
- 11.2.1.6.3 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
- 11.2.1.6.4 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AbbVie Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Bausch Health Companies Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Novartis AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Clearside Biomedical, Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Alimera Sciences, Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 GRAYBUG VISION, INC
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Europe Ocular Drug Delivery Market
